Naoto Kamiya

1.9k total citations
87 papers, 1.4k citations indexed

About

Naoto Kamiya is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Naoto Kamiya has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 20 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Surgery. Recurrent topics in Naoto Kamiya's work include Prostate Cancer Treatment and Research (43 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Naoto Kamiya is often cited by papers focused on Prostate Cancer Treatment and Research (43 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Naoto Kamiya collaborates with scholars based in Japan and United States. Naoto Kamiya's co-authors include Hiroyoshi Suzuki, Tomohiko Ichikawa, Takashi Imamoto, Koji Kawamura, Akira Komiya, Yukio Naya, Masashi Yano, Takanobu Utsumi, Haruo Itô and Koichiro Akakura and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Annals of Oncology.

In The Last Decade

Naoto Kamiya

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoto Kamiya Japan 22 796 359 345 338 283 87 1.4k
Charlotte Becker Sweden 25 1.0k 1.3× 355 1.0× 156 0.5× 217 0.6× 193 0.7× 46 1.7k
Torvald Granfors Sweden 24 1.0k 1.3× 534 1.5× 123 0.4× 303 0.9× 332 1.2× 40 1.8k
Yong Mee Cho South Korea 22 807 1.0× 687 1.9× 206 0.6× 491 1.5× 449 1.6× 100 1.8k
Akira Komiya Japan 29 1.4k 1.8× 943 2.6× 503 1.5× 300 0.9× 438 1.5× 99 2.4k
Arne Strauß Germany 17 569 0.7× 453 1.3× 91 0.3× 326 1.0× 125 0.4× 61 1.1k
Egils Vjaters Latvia 14 999 1.3× 244 0.7× 207 0.6× 159 0.5× 227 0.8× 51 1.4k
Marinus A. Noordzij Netherlands 17 988 1.2× 625 1.7× 224 0.6× 96 0.3× 296 1.0× 29 1.4k
Toshinari Yamasaki Japan 23 684 0.9× 581 1.6× 84 0.2× 194 0.6× 391 1.4× 117 1.4k
Hisashi Hasumi Japan 20 697 0.9× 700 1.9× 114 0.3× 145 0.4× 173 0.6× 73 1.4k
J. W. Clark United States 15 937 1.2× 443 1.2× 273 0.8× 90 0.3× 490 1.7× 26 1.5k

Countries citing papers authored by Naoto Kamiya

Since Specialization
Citations

This map shows the geographic impact of Naoto Kamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoto Kamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoto Kamiya more than expected).

Fields of papers citing papers by Naoto Kamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoto Kamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoto Kamiya. The network helps show where Naoto Kamiya may publish in the future.

Co-authorship network of co-authors of Naoto Kamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Naoto Kamiya. A scholar is included among the top collaborators of Naoto Kamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoto Kamiya. Naoto Kamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Ikeda, Ryusuke, et al.. (2025). Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-Oncology. Cancers. 17(20). 3367–3367. 1 indexed citations
5.
Suzuki, Yuta, et al.. (2025). Impact of the COVID ‐19 Pandemic on Prostate Cancer: Perturbations in Screening and Diagnostic Patterns. International Journal of Urology. 32(8). 990–996. 2 indexed citations
6.
Suzuki, Yuta, et al.. (2025). Development, Validation, and Clinical Utility of a Nomogram for Urological Tumors: How to Build the Best Predictive Model. International Journal of Urology. 32(8). 919–931. 3 indexed citations
7.
8.
Kamiya, Naoto, Taro Okazaki, Yuta Suzuki, et al.. (2025). Multidisciplinary Treatment for Lymphorrhea and Chylorrhea Following Lymph Node Dissection for Genitourinary Cancer. Cancers. 17(4). 592–592.
9.
Kato, Takuma, Akira Yokomizo, Ryuji Matsumoto, et al.. (2022). Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study. International Journal of Urology. 29(11). 1271–1278. 5 indexed citations
10.
Matsubara, Nobuaki, Yoko Yamada, Ken‐ichi Tabata, et al.. (2017). Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 16(2). 142–148. 29 indexed citations
11.
Utsumi, Takanobu, Naoto Kamiya, Takumi Endo, et al.. (2017). Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism. World Journal of Urology. 35(10). 1577–1583. 16 indexed citations
12.
Yano, Masashi, Ryuji Sakakibara, Fuyuki Tateno, et al.. (2016). Urodynamic findings in patients with Creutzfeldt–Jakob disease: a case report. International Urology and Nephrology. 48(10). 1579–1583. 2 indexed citations
13.
Matsubara, Nobuaki, Itsuhiro Takizawa, Tsutomu Nishiyama, et al.. (2015). A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer. Japanese Journal of Clinical Oncology. 45(8). 774–779. 8 indexed citations
14.
Utsumi, Takanobu, Koji Kawamura, Takashi Imamoto, et al.. (2014). Assessment of postoperative changes in antihypertensive drug consumption in patients with primary aldosteronism using the defined daily dose. Asian Journal of Surgery. 37(4). 190–194. 8 indexed citations
15.
Kamiya, Naoto, Hiroyoshi Suzuki, Takumi Endo, et al.. (2011). Additive effect of zoledronic acid on serum prostate‐specific antigen changes for hormone‐sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade. International Journal of Urology. 19(2). 169–173. 15 indexed citations
16.
Komaru, Atsushi, Naoto Kamiya, Hidenori Suzuki, et al.. (2010). Implications of Body Mass Index in Japanese Patients with Prostate Cancer Who Had Undergone Radical Prostatectomy. Japanese Journal of Clinical Oncology. 40(4). 353–359. 13 indexed citations
17.
Utsumi, Takanobu, Koji Kawamura, Hiroyoshi Suzuki, et al.. (2009). External validation and head‐to‐head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets. International Journal of Urology. 16(4). 416–419. 16 indexed citations
18.
Ueda, Takeshi, Hiroyoshi Suzuki, Koichiro Akakura, et al.. (2006). Bisphosphonate and low-dose dexamethasone treatment for patients with hormone-refractory prostate cancer.. PubMed. 52(7). 515–21. 3 indexed citations
19.
Suzuki, Hiroyoshi, Naoto Kamiya, Masaki Shimbo, et al.. (2004). Clinical evaluation of transrectal power Doppler imaging in the detection of prostate cancer. International Urology and Nephrology. 36(2). 175–180. 24 indexed citations
20.
Suzuki, Hiroyoshi, Tomohiko Ichikawa, Nobuyuki Sekita, et al.. (2001). Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer. The Prostate. 49(2). 110–115. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Becker Breakdown of academic impact, for papers by Torvald Granfors Breakdown of academic impact, for papers by Yong Mee Cho Breakdown of academic impact, for papers by Akira Komiya Breakdown of academic impact, for papers by Arne Strauß Breakdown of academic impact, for papers by Egils Vjaters Breakdown of academic impact, for papers by Marinus A. Noordzij Breakdown of academic impact, for papers by Toshinari Yamasaki Breakdown of academic impact, for papers by Hisashi Hasumi Breakdown of academic impact, for papers by J. W. Clark
Rankless by CCL
2026